Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cellectar Biosciences Receives Rare Pediatric Disease Designation From FDA For Iopofosine I 131 In Relapsed or Refractory Pediatric High-Grade Glioma

Author: Benzinga Newsdesk | October 27, 2025 07:32am

Posted In: CLRB